Healthcare

Imricor Medical Systems (ASX:IMR) reported in its August 2026 quarterly activities update that its US commercial launch had begun. It identified Rady Children’s Hospital–San Diego as its first US customer for the NorthStar platform and described the establishment of a cardiac catheterisation program using …

Healius (ASX:HLS) reported FY26 group revenue of approximately AUD 1.37 billion, an increase of 2.1%. Underlying EBITDA was AUD 258.6 million, up 8.1%, while underlying EBIT was AUD 30.2 million, up 76.6%. These numbers indicate improvement on management’s underlyingEarningsdefinitions but do not eliminate the …

Clinuvel Pharmaceuticals (ASX:CUV) reportedRevenueof AUD 94.0 million and profit before tax of AUD 47.7 million for FY26. It disclosed cash reserves of AUD 252.1 million using a specified non-IFRS measure. Because the reserve number is not necessarily identical to a single statutory balance-sheet line, …

AVITA Medical (ASX:AVH) reported second-quarter 2026 revenue growth of 18% year on year and 13% sequentially. Operating expenses were USD 24.6 million, down 6% from the corresponding quarter. Net cash use was approximately USD 3.2 million, compared with USD 9.9 million in the first …

Monash IVF Group (ASX:MVF) reported FY26 revenue of AUD 269.5 million, a decline of 0.9%, while underlying EBITDA decreased 19.5% to AUD 53.4 million. Underlying net profit after tax was AUD 16.1 million, down 41.2%. Its underlying EBITDAMarginwas 19.8%, compared with 24.4% in the …

Racura Oncology (ASX:RAC) reported that the first patient had been treated with RC220 in combination with osimertinib in its HARNESS-1 study for EGFR-mutated non-small cell lung cancer. The company also described expanded study access in New South Wales and Victoria following ethics approvals. These …

The decision followed a pre-NDA meeting with the FDA this fall and was recently approved by the board.